Dr. Martin Lerner:
Frequently Asked Questions: Cardiac abnormalities in CFS patients; diagnosis; treatment of EBV, HCMV and HHV6; recent research.
Dr. Lerner on his Long Lerm Antiviral Treatment Study: The effectiveness of long term antiviral therapy on CFS and orthostatic intolerance in 142 patients seen more than 7000 times over six years.
Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
David H. P. Streeten, MB, DPhil, FRCP, FACP and David S. Bell, MD, FAAP:
Circulating Blood Volume in Chronic Fatigue Syndrome
Dr. Jacob Teitelbaum:
Treating Low Blood Volume and Decreased Heart Function in CFS
Note that the above papers and articles are just the tip of the iceberg; there is a great deal of information available on studies and other evidence supporting the connection between CFS, low blood volume, and cardiomyopathy.
Dr. Judy Mikovits, lead researcher in the recent study linking CFS/ME with the XMRV retrovirus, believes that XMRV impairs the immune system in such a way that other pathogens, such as EBV, HCMV, and HHV6, can thrive.
Until this enabling relationship is proven and effective treatments for XMRV are found, Dr. Lerner's antiviral treatment makes a great deal of sense, especially given his well-documented success.
Update: Read this newsletter from Dr. David Bell, who treated CFS patients for over 25 years. Dr. Bell has some interesting insights into the XMRV research to date as well as the political context surrounding CFS-related research.
Dr. Bell also lists a number of readily available lab tests which he believes can be used to detect and/or confirm the presence of CFS in patients, including echocardiogram with cardiac output while standing and IVRT interrogation with oxygen.
Quick link to this page: http://tinyurl.com/cfs-cardio
No comments:
Post a Comment